Asia-Pacific Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
NEW YORK, Dec. 28, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Asia-Pacific Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
http://www.reportlinker.com/p0739467/Asia-Pacific-Diabetes-Care-Devices-Market-Outlook-to-2017--Glucose-Monitoring-and-Insulin-Delivery.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Pathology
Asia-Pacific Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
Summary
GlobalData's new report, "Asia-Pacific Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery" provides key market data on the Asia-Pacific Diabetes Care Devices market – Australia, China, India and Japan. The report provides value (USD million) data for all the market categories – Glucose Monitoring and Insulin Delivery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Countries covered include Australia, China, India and Japan.
- Market size and company share data for Diabetes Care Devices market categories – Glucose Monitoring and Insulin Delivery.
- Annualized market revenues (USD million) data for each of the market categories in each of the country. Data from 2003 to 2010, forecast forward for 7 years to 2017.
- 2010 company shares and distribution shares data for each of the market categories and countries.
- Global corporate-level profiles of key companies operating within the Asia-Pacific Diabetes Care Devices market..
- Key players covered include F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, LifeScan, Inc., Eli Lilly and Company, ARKRAY, Inc., Medtronic, Inc. and others.
Reasons to buy
- Develop business strategies by identifying the key market categories and segments poised for strong growth.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the Asia-Pacific Diabetes Care Devices competitive landscape.
- Develop capital investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and what's the most preferred mode of product distribution – Identify, understand and capitalize.
1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 7
1.2 List of Figures 9
2 Introduction 11
2.1 What is This Report About? 11
3 Diabetes Care Devices in Asia-Pacific 12
3.1 Diabetes Care Devices Cross Country Comparison, USD Actual, 2003-2017 12
3.2 Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Actual, 2003-2017 13
3.3 Diabetes Care Devices, Asia-Pacific, Category Volume (Units), 2003-2017 16
3.4 Diabetes Care Devices, Asia-Pacific, Company share (2009-2010) 19
4 Diabetes Care Devices In Japan 21
4.1 Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, 2003-2017 21
4.2 Diabetes Care Devices, Japan, Category Volume (Units), 2003-2017 25
4.3 Diabetes Care Devices, Japan, Distribution Share (2009-2010) 28
4.3.1 Glucose Monitoring, Japan, Distribution Share (2009-2010) 28
4.3.2 Insulin Delivery, Japan, Distribution Share (2009-2010) 28
4.4 Diabetes Care Devices, Japan, Company Share (2009-2010) 29
4.4.1 Diabetes Care Devices, Japan, Company Share (2009-2010) 29
4.4.2 Glucose Monitoring, Japan, Company share (2009-2010) 31
4.4.3 Insulin Delivery, Japan, Company share (2009-2010) 33
5 Diabetes Care Devices In India 35
5.1 Diabetes Care Devices, India, Overall Revenue ($m), USD Actual, 2003-2017 35
5.2 Diabetes Care Devices, India, Category Volume (Units), 2003-2017 38
5.3 Diabetes Care Devices, India, Distribution Share (2009-2010) 41
5.3.1 Glucose Monitoring, India, Distribution Share (2009-2010) 41
5.3.2 Insulin Delivery, India, Distribution Share (2009-2010) 41
5.4 Diabetes Care Devices, India, Company share (2009-2010) 42
5.4.1 Diabetes Care Devices, India, Company share (2009-2010) 42
5.4.2 Glucose Monitoring, India, Company share (2009-2010) 44
5.4.3 Insulin Delivery, India, Company share (2009-2010) 46
6 Diabetes Care Devices In Australia 47
6.1 Diabetes Care Devices, Australia, Overall Revenue ($m), USD Actual, 2003-2017 47
6.2 Diabetes Care Devices, Australia, Category Volume (Units), 2003-2017 52
6.3 Diabetes Care Devices, Australia, Distribution Share (2009-2010) 55
6.3.1 Glucose Monitoring, Australia, Distribution Share (2009-2010) 55
6.3.2 Insulin Delivery, Australia, Distribution Share (2009-2010) 55
6.4 Diabetes Care Devices, Australia, Company share (2009-2010) 56
6.4.1 Diabetes Care Devices, Australia, Company share (2009-2010) 56
6.4.2 Glucose Monitoring, Australia, Company share (2009-2010) 58
6.4.3 Insulin Delivery, Australia, Company share (2009-2010) 60
7 Diabetes Care Devices In China 62
7.1 Diabetes Care Devices, China, Overall Revenue ($m), USD Actual, 2003-2017 62
7.2 Diabetes Care Devices, China, Category Volume (Units), 2003-2017 67
7.3 Diabetes Care Devices, China, Distribution Share (2009-2010) 72
7.3.1 Glucose Monitoring, China, Distribution Share (2009-2010) 72
7.3.2 Insulin Delivery, China, Distribution Share (2009-2010) 72
7.4 Diabetes Care Devices, China, Company share (2009-2010) 73
7.4.1 Diabetes Care Devices, China, Company share (2009-2010) 73
7.4.2 Glucose Monitoring, China, Company share (2009-2010) 75
7.4.3 Insulin Delivery, China, Company share (2009-2010) 77
8 Overview of Key Companies in Asia-Pacific Diabetes Care Devices Market 79
8.1 F. Hoffmann-La Roche Ltd. 79
8.1.1 Company Overview 79
8.1.2 Share in the Asia-Pacific Diabetes Care Devices Market 79
8.2 Novo Nordisk A/S 80
8.2.1 Company Overview 80
8.2.2 Share in the Asia-Pacific Diabetes Care Devices Market 80
8.3 LifeScan, Inc. 81
8.3.1 Company Overview 81
8.3.2 Share in the Asia-Pacific Diabetes Care Devices Market 81
8.4 Eli Lilly and Company 82
8.4.1 Company Overview 82
8.4.2 Share in the Asia-Pacific Diabetes Care Devices Market 82
8.5 ARKRAY, Inc. 83
8.5.1 Company Overview 83
8.5.2 Share in the Asia-Pacific Diabetes Care Devices Market 83
8.6 Medtronic, Inc. 84
8.6.1 Company Overview 84
8.6.2 Share in the Asia-Pacific Diabetes Care Devices Market 84
8.7 Sanofi 85
8.7.1 Company Overview 85
8.8 Abbott Laboratories 85
8.8.1 Company Overview 85
8.9 Bayer HealthCare AG 85
8.9.1 Company Overview 85
8.10 Terumo Corporation 86
8.10.1 Company Overview 86
8.11 Becton, Dickinson and Company 86
8.11.1 Company Overview 86
8.12 Animas Corporation 86
8.12.1 Company Overview 86
8.13 Hindustan Syringes & Medical Devices Ltd. 87
8.13.1 Company Overview 87
8.14 NIPRO CORPORATION 87
8.14.1 Company Overview 87
8.15 B. Braun Melsungen AG 87
8.15.1 Company Overview 87
9 Diabetes Care Devices Market Pipeline Products 88
10 Financial Deals Landscape 91
10.1 Partnerships 91
10.1.1 PositiveID Enters Into Agreement with HMD BioMedical 91
10.1.2 Powder Pharmaceuticals Enters Into An Agreement With Health-Chem Diagnostics 92
10.1.3 ZyXEL Communications Enters Into Strategic Partnership With Entra Health Systems 93
11 Recent Developments 94
11.1 Strategy and Business Planning 94
11.1.1 Nov 04, 2011: Takeda Announces New Structure Of Business Operations 94
11.1.2 Sep 06, 2011: Golden Meditech Launches Representative Office In Taiwan 94
11.1.3 Jun 22, 2011: Johnson & Johnson Opens Innovation Center In China 95
11.1.4 May 12, 2011: MicroPort Establishes Wholly Owned Subsidiary In Jiaxing, China 95
11.1.5 Apr 28, 2011: Takeda Announces Establishment Of New Sales And Marketing Company In China 96
11.1.6 Mar 25, 2011: Takeda Plans To Expand Sales Force And To Enhance Business Infrastructure In China 96
11.1.7 Mar 09, 2011: Medtronic Inaugurates New Manufacturing Facility In Singapore 97
11.1.8 Jan 17, 2011: Smiths Medical To Set Up Subsidiary In India 97
11.2 Government and Public Interest 98
11.2.1 Jun 15, 2011: Takeda To Start Internship Program For Tsinghua University Of China 98
11.2.2 Feb 21, 2011: Takeda Recalls Anti-Inflammatory Enzyme Preparation, Dasen In Japan 98
11.2.3 Jan 27, 2011: China's Ministry Of Commerce Grants Clearance For Merger Of BMP Sunstone And sanofi-aventis Subsidiary 99
12 Appendix 100
12.1 Definitions of Markets Covered in the Report 101
12.1.1 Diabetes Care Devices 101
12.2 Research Methodology 102
12.3 Secondary Research 102
12.4 Primary Research 103
12.5 Models 103
12.6 Forecasts 104
12.7 Expert Panels 104
12.8 GlobalData Consulting 104
12.9 Currency Conversion 105
12.10 Contact Us 105
12.11 Disclaimer 105
List of Tables
Table 1: Diabetes Care Devices, Cross Country Comparison, USD Actual, 2003-2017 12
Table 2: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Actual, 2003-2017 13
Table 3: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Actual, Historic, 2003-2010 14
Table 4: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 15
Table 5: Diabetes Care Devices, Asia-Pacific, Category Volume (Units), 2003-2017 16
Table 6: Diabetes Care Devices, Asia-Pacific, Category Volume (Units), Historic, 2003-2010 17
Table 7: Diabetes Care Devices, Asia-Pacific, Category Volume (Units), Forecast, 2010-2017 18
Table 8: Diabetes Care Devices, Asia-Pacific, Company share by Revenue ($m), USD Actual, 2009-2010 20
Table 9: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, 2003-2017 21
Table 10: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, Historic, 2003-2010 22
Table 11: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 24
Table 12: Diabetes Care Devices, Japan, Category Volume (Units), 2003-2017 25
Table 13: Diabetes Care Devices, Japan, Category Volume (Units), Historic, 2003-2010 26
Table 14: Diabetes Care Devices, Japan, Category Volume (Units), Forecast, 2010-2017 27
Table 15: Glucose Monitoring, Japan, Distribution Share by Revenue ($m), USD Actual, 2009-2010 28
Table 16: Insulin Delivery, Japan, Distribution Share by Revenue ($m), USD Actual, 2009-2010 28
Table 17: Diabetes Care Devices, Japan, Company Share by Revenue ($m), USD Actual, 2009-2010 30
Table 18: Glucose Monitoring, Japan, Company share by Revenue ($m), USD Actual 2009-2010 32
Table 19: Insulin Delivery, Japan, Company share by Revenue ($m), USD Actual 2009-2010 34
Table 20: Diabetes Care Devices, India, Overall Revenue ($m), USD Actual, 2003-2017 35
Table 21: Diabetes Care Devices, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 36
Table 22: Diabetes Care Devices, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 37
Table 23: Diabetes Care Devices, India, Category Volume (Units), 2003-2017 38
Table 24: Diabetes Care Devices, India, Category Volume (Units), Historic, 2003-2010 39
Table 25: Diabetes Care Devices, India, Category Volume (Units), Forecast, 2010-2017 40
Table 26: Glucose Monitoring, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 41
Table 27: Insulin Delivery, India, Distribution Share by Revenue ($m), USD Actual, 2009-2010 41
Table 28: Diabetes Care Devices, India, Company share by Revenue ($m), USD Actual, 2009-2010 43
Table 29: Glucose Monitoring, India, Company share by Revenue ($m), USD Actual 2009-2010 45
Table 30: Insulin Delivery, India, Company share by Revenue ($m), USD Actual 2009-2010 46
Table 31: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Actual, 2003-2017 47
Table 32: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Actual, Historic, 2003-2010 49
Table 33: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 51
Table 34: Diabetes Care Devices, Australia, Category Volume (Units), 2003-2017 52
Table 35: Diabetes Care Devices, Australia, Category Volume (Units), Historic, 2003-2010 53
Table 36: Diabetes Care Devices, Australia, Category Volume (Units), Forecast, 2010-2017 54
Table 37: Glucose Monitoring, Australia, Distribution Share by Revenue ($m), USD Actual, 2009-2010 55
Table 38: Insulin Delivery, Australia, Distribution Share by Revenue ($m), USD Actual, 2009-2010 55
Table 39: Diabetes Care Devices, Australia, Company share by Revenue ($m), USD Actual, 2009-2010 57
Table 40: Glucose Monitoring, Australia, Company share by Revenue ($m), USD Actual 2009-2010 59
Table 41: Insulin Delivery, Australia, Company share by Revenue ($m), USD Actual 2009-2010 61
Table 42: Diabetes Care Devices, China, Overall Revenue ($m), USD Actual, 2003-2017 62
Table 43: Diabetes Care Devices, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 64
Table 44: Diabetes Care Devices, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 66
Table 45: Diabetes Care Devices, China, Category Volume (Units), 2003-2017 67
Table 46: Diabetes Care Devices, China, Category Volume (Units), Historic, 2003-2010 69
Table 47: Diabetes Care Devices, China, Category Volume (Units), Forecast, 2010-2017 71
Table 48: Glucose Monitoring, China, Distribution Share by Revenue ($m), USD Actual, 2009-2010 72
Table 49: Insulin Delivery, China, Distribution Share by Revenue ($m), USD Actual, 2009-2010 72
Table 50: Diabetes Care Devices, China, Company share by Revenue ($m), USD Actual, 2009-2010 74
Table 51: Glucose Monitoring, China, Company share by Revenue ($m), USD Actual 2009-2010 76
Table 52: Insulin Delivery, China, Company share by Revenue ($m), USD Actual 2009-2010 78
Table 53: Diabetes Care Devices Market Pipeline Products 88
Table 54: PositiveID Enters Into Agreement With HMD BioMedical 91
Table 55: Powder Pharmaceuticals Enters Into An Agreement With Health-Chem Diagnostics 92
Table 56: ZyXEL Communications Enters Into Strategic Partnership With Entra Health Systems 93
Table 57: USD to Local Currency, Asia-Pacific, Average Exchange Rate 2003-2010 105
List of Figures
Figure 1: Diabetes Care Devices, Cross Country Comparison, USD Actual, 2003-2017 12
Figure 2: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Actual, 2003-2017 13
Figure 3: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Actual, Historic, 2003-2010 14
Figure 4: Diabetes Care Devices, Asia-Pacific, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 15
Figure 5: Diabetes Care Devices, Asia-Pacific, Category Volume (Units), 2003-2017 16
Figure 6: Diabetes Care Devices, Asia-Pacific, Category Volume (Units), Historic, 2003-2010 17
Figure 7: Diabetes Care Devices, Asia-Pacific, Category Volume (Units), Forecast, 2010-2017 18
Figure 8: Diabetes Care Devices, Asia-Pacific, Company share (%), 2010 19
Figure 9: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, 2003-2017 21
Figure 10: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, Historic, 2003-2010 22
Figure 11: Diabetes Care Devices, Japan, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 23
Figure 12: Diabetes Care Devices, Japan, Category Volume (Units), 2003-2017 25
Figure 13: Diabetes Care Devices, Japan, Category Volume (Units), Historic, 2003-2010 26
Figure 14: Diabetes Care Devices, Japan, Category Volume (Units), Forecast, 2010-2017 27
Figure 15: Diabetes Care Devices, Japan, Company Share (%), 2010 29
Figure 16: Glucose Monitoring, Japan, Company share (%), 2010 31
Figure 17: Insulin Delivery, Japan, Company share (%), 2010 33
Figure 18: Diabetes Care Devices, India, Overall Revenue ($m), USD Actual, 2003-2017 35
Figure 19: Diabetes Care Devices, India, Overall Revenue ($m), USD Actual, Historic, 2003-2010 36
Figure 20: Diabetes Care Devices, India, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 37
Figure 21: Diabetes Care Devices, India, Category Volume (Units), 2003-2017 38
Figure 22: Diabetes Care Devices, India, Category Volume (Units), Historic, 2003-2010 39
Figure 23: Diabetes Care Devices, India, Category Volume (Units), Forecast, 2010-2017 40
Figure 24: Diabetes Care Devices, India, Company share (%), 2010 42
Figure 25: Glucose Monitoring, India, Company share (%), 2010 44
Figure 26: Insulin Delivery, India, Company share (%), 2010 46
Figure 27: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Actual, 2003-2017 47
Figure 28: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Actual, Historic, 2003-2010 48
Figure 29: Diabetes Care Devices, Australia, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 50
Figure 30: Diabetes Care Devices, Australia, Category Volume (Units), 2003-2017 52
Figure 31: Diabetes Care Devices, Australia, Category Volume (Units), Historic, 2003-2010 53
Figure 32: Diabetes Care Devices, Australia, Category Volume (Units), Forecast, 2010-2017 54
Figure 33: Diabetes Care Devices, Australia, Company share (%), 2010 56
Figure 34: Glucose Monitoring, Australia, Company share (%), 2010 58
Figure 35: Insulin Delivery, Australia, Company share (%), 2010 60
Figure 36: Diabetes Care Devices, China, Overall Revenue ($m), USD Actual, 2003-2017 62
Figure 37: Diabetes Care Devices, China, Overall Revenue ($m), USD Actual, Historic, 2003-2010 63
Figure 38: Diabetes Care Devices, China, Overall Revenue ($m), USD Actual, Forecast, 2010-2017 65
Figure 39: Diabetes Care Devices, China, Category Volume (Units), 2003-2017 67
Figure 40: Diabetes Care Devices, China, Category Volume (Units), Historic, 2003-2010 68
Figure 41: Diabetes Care Devices, China, Category Volume (Units), Forecast, 2010-2017 70
Figure 42: Diabetes Care Devices, China, Company share (%), 2010 73
Figure 43: Glucose Monitoring, China, Company share (%), 2010 75
Figure 44: Insulin Delivery, China, Company share (%), 2010 77
Figure 45: F. Hoffmann-La Roche Ltd., Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2010 79
Figure 46: Novo Nordisk A/S, Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2010 80
Figure 47: LifeScan, Inc., Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2010 81
Figure 48: Eli Lilly and Company, Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2010 82
Figure 49: ARKRAY, Inc., Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2010 83
Figure 50: Medtronic, Inc., Company Share (%), Asia-Pacific Diabetes Care Devices Market, 2010 84
Companies mentioned
F. Hoffmann-La Roche Ltd.
Novo Nordisk A/S
LifeScan, Inc.
Eli Lilly and Company
ARKRAY, Inc.
Medtronic, Inc.
Sanofi
Abbott Laboratories
Bayer HealthCare AG
Terumo Corporation
Becton, Dickinson and Company
Animas Corporation
Hindustan Syringes & Medical Devices Ltd.
NIPRO CORPORATION
B. Braun Melsungen AG
To order this report:
Pathology Industry: Asia-Pacific Diabetes Care Devices Market Outlook to 2017- Glucose Monitoring and Insulin Delivery
Check our Industry Analysis and Insights
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article